Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2023	Dec. 31, 2022
Real estate assets:
Land	[1]	$ 590,327	$ 596,715
Buildings and improvements	[1]	1,194,887	1,198,597
Real estate assets	[1]	1,785,214	1,795,312
Accumulated depreciation	[1]	(161,466)	(136,901)
Real estate investment property, net, before developments in progress	[1]	1,623,748	1,658,411
Developments in progress	[1]	7,162	5,576
Net investment in real estate assets	[1]	1,630,910	1,663,987
Cash and cash equivalents	[1]	22,555	44,718
Restricted cash	[1]	72,432	97,231
Available-for-sale securities - at fair value (amortized cost of $259,928 and $293,476 as of March 31, 2023 and December 31, 2022, respectively)	[1]	259,404	292,422
Receivables:
Tenant	[1]	32,590	40,620
Other	[1]	4,203	3,876
Investments in unconsolidated affiliates	[1]	75,900	77,295
In-place leases, net	[1]	219,391	247,497
Above market leases, net	[1]	156,274	171,265
Intangible lease assets and other assets	[1]	42,132	39,332
Total assets	[1]	2,515,791	2,678,243
LIABILITIES AND EQUITY
Mortgage and other indebtedness, net		1,946,429	2,000,186
Below market leases, net		101,628	110,616
Accounts payable and accrued liabilities		110,129	200,312
Total liabilities	[1]	2,158,186	2,311,114
Shareholders' equity:
Common stock, $.001 par value, 200,000,000 shares authorized, 32,060,956 and 31,780,109 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		32	32
Additional paid-in capital		711,956	710,497
Accumulated other comprehensive loss		(524)	(1,054)
Accumulated deficit		(348,699)	(338,934)
Total shareholders' equity		362,765	370,541
Noncontrolling interests		(5,160)	(3,412)
Total equity		357,605	367,129
Total liabilities, redeemable noncontrolling interests and equity		$ 2,515,791	$ 2,678,243

[1] As of March 31, 2023, includes $187,693 of assets related to consolidated variable interest entities that can be used only to settle obligations of the consolidated variable interest entities and $203,730 of liabilities of consolidated variable interest entities for which creditors do not have recourse to the general credit of the Company. See Note 7.